Literature DB >> 25726369

[Relationship between vitamin D deficiency and metabolic syndrome in adult population of the Community of Madrid].

Antonio Gradillas-García1, Julia Álvarez2, José Antonio Rubio3, Francisco J de Abajo4.   

Abstract

BACKGROUNDS AND
OBJECTIVE: Previous studies have suggested an association between MS and vitamin D deficiency, but data are not conclusive. This study was intended to find out if metabolic syndrome, according to the 2009 IDF/AHA/NHLBI, is associated to the presence of vitamin D deficiency.
MATERIAL AND METHODS: A cross-sectional study was conducted on a sample of 326 subjects aged 18 years or older, recruited from a health center in Alcalá de Henares. Participants underwent an interview and a standardized clinical examination. In a second visit, blood tests were performed in 255 subjects to quantify serum levels of 25-hydroxyvitamin D (25 OH-VitD) and different laboratory parameters associated to MS. The association between vitamin D deficiency and metabolic syndrome (and each of its components) was examined.
RESULTS: In the study population, MS prevalence was 36.1% and prevalence of vitamin D deficiency (25 OH-Vit D<20 ng/mL) was 56.3%. MS was more common in the group of patients with vitamin D deficiency (43.4%) than in the group with no deficiency (26.8%, P=.006), with an estimated prevalence ratio of 1.62 (95% CI: 1.13-2.31). Adjustment for age, sex, and body mass index did not change such association.
CONCLUSIONS: There is a significant association between vitamin D deficiency and MS. Both conditions are highly prevalent in our population.
Copyright © 2014 SEEN. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Diabetes tipo 2; Metabolic syndrome; Síndrome metabólico; Type 2 diabetes; Vitamin D; Vitamina D

Mesh:

Substances:

Year:  2015        PMID: 25726369     DOI: 10.1016/j.endonu.2014.12.008

Source DB:  PubMed          Journal:  Endocrinol Nutr        ISSN: 1575-0922


  6 in total

1.  Vitamin D Levels as an Important Predictor for Type 2 Diabetes Mellitus and Weight Regain Post-Sleeve Gastrectomy.

Authors:  Alanoud Aladel; Alice M Murphy; Jenny Abraham; Neha Shah; Thomas M Barber; Graham Ball; Vinod Menon; Milan K Piya; Philip G McTernan
Journal:  Nutrients       Date:  2022-05-13       Impact factor: 6.706

2.  Risk of Ischemic Stroke Associated With Calcium Supplements With or Without Vitamin D: A Nested Case-Control Study.

Authors:  Francisco J de Abajo; Sara Rodríguez-Martín; Antonio Rodríguez-Miguel; Miguel J Gil
Journal:  J Am Heart Assoc       Date:  2017-05-18       Impact factor: 5.501

3.  Effects of vitamin D supplementation on cardiovascular risk factors in shift workers: Study protocol for randomized, double-blind, placebo-controlled clinical trial.

Authors:  Virginia Capistrano Fajardo; Fernando Luiz Pereira de Oliveira; George Luiz Lins Machado-Coelho; Fausto Aloísio Pedrosa Pimenta; Silvia Nascimento de Freitas; Antônio Luiz Pinho Ribeiro; Maria Marta Sarquis Soares; Marcio Weissheimer Lauria; Rosielle da Costa Farias; Ive Bahia França; Raimundo Marques do Nascimento Neto
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Risk of Myocardial Infarction Among New Users of Calcium Supplements Alone or Combined With Vitamin D: A Population-Based Case-Control Study.

Authors:  Sara Rodríguez-Martín; Diana González-Bermejo; Antonio Rodríguez-Miguel; Diana Barreira; Alberto García-Lledó; Miguel Gil; Francisco J de Abajo
Journal:  Clin Pharmacol Ther       Date:  2019-11-06       Impact factor: 6.875

5.  A Novel Biosensor and Algorithm to Predict Vitamin D Status by Measuring Skin Impedance.

Authors:  Jin-Chul Heo; Doyoon Kim; Hyunsoo An; Chang-Sik Son; Sangwoo Cho; Jong-Ha Lee
Journal:  Sensors (Basel)       Date:  2021-12-04       Impact factor: 3.576

Review 6.  Role of Vitamin D in the Metabolic Syndrome.

Authors:  Lucía Melguizo-Rodríguez; Víctor J Costela-Ruiz; Enrique García-Recio; Elvira De Luna-Bertos; Concepción Ruiz; Rebeca Illescas-Montes
Journal:  Nutrients       Date:  2021-03-03       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.